Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review

Third-generation intravenous (i.v.) iron preparations are safe and efficacious and are increasingly used in the treatment of iron-deficiency anaemia. Hypophosphataemia is emerging as an established side-effect following the administration of certain compounds. Symptoms of hypophosphataemia can be ma...

Full description

Bibliographic Details
Main Authors: Xenophon Kassianides, Sunil Bhandari
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-01-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/hypophosphataemia,-fibroblast-growth-factor-23,-and-third-generation-intravenous-iron-compounds:-a-narrative-review